About

Paul Martin is Head of Business Development at Copley Scientific. With more than a decade of experience in the inhaled drug delivery sector, he has a strong understanding of compendial testing requirements for orally inhaled and nasal drug products (OINDPs). He works closely with pharmaceutical and development teams to support complex programmes, with expertise in delivered dose uniformity and aerodynamic particle size distribution testing.

Mr Martin supports organisations in interpreting evolving regulatory expectations and implementing robust, compliant OINDP test strategies. His approach centres on helping customers refine test set-ups to improve clinical relevance, strengthen in vitro-in vivo correlations and gain deeper insight from their data, ensuring that they derive maximum value from their analytical equipment and development activities.